VySpine Gains FDA 510(k) for LumiVy Lumbar IBF with NanoVy Ti

VySpine received FDA 510(k) clearance to market its LumiVy NanoVy Ti Lumbar IBF System, indicated for intervertebral body fusion at either one level or two contiguous levels in the lumbar spine for the treatment of degenerative disc disease with up to Grade 1 spondylolisthesis.

The LumiVy NanoVy Ti Lumbar IBF System features VySpine's NanoVy...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0